Disappointed investors punished Wave Life Sciences (NASDAQ: WVE), causing its shares to lose roughly half their value on Thursday after the RNA-based drug developer reported mixed early-stage interim ...

The 24 students are the first members of the Class of 2027 to be tapped for the honor, which recognizes “breadth of interest, ...

‘If the vial is not prepared correctly and it’s not sterile, there’s a real risk of infection’ warns Dr McGuire, and without ...

A Gravity Theory That Could Rewrite the Universe’s First Moments The first fraction of a second after the Big Bang has always ...

Noise: The industry obsesses over dollar figures while obscuring the hidden temporal costs that sink most projects. Direct ...

MaxCyte, Inc. (NASDAQ:MXCT) Q4 2025 Earnings Call Transcript March 24, 2026 MaxCyte, Inc. misses on earnings expectations. Reported EPS is $-0.09016 EPS, expectations were $-0.06505. Operator: Good ...

The ‘This is an Xbox’ campaign is gone, marking the new era for Xbox under boss Asha Sharma; what happens to Xbox Cloud ...

When Is the Next Crypto Bull Run 2026, what could set it in motion, the standout themes to track, and the answers to common questions. With each calendar turn, market watchers reset expectations. The ...

Reddit has introduced human verification requirements for suspicious accounts, deploying passkeys, biometrics, and a new bot ...

Findings has critical implications for predicting extreme weather events such as hurricanes and heavy rainfall. In a groundbreaking meteorological study, an international team of researchers from the ...

At 6-month follow-up, a single 240 mg dose of WVE-007 (INHBE GalNAc-siRNA) continued to drive significant placebo-adjusted ...

WAVE Life Sciences (NASDAQ:WVE) highlighted positive interim data from the ongoing Phase 1 INLIGHT trial of WVE-007, a GalNAc ...